Filter News
Area of Research
- (-) Materials for Computing (10)
- (-) Nuclear Science and Technology (2)
- Biological Systems (1)
- Biology and Environment (27)
- Clean Energy (72)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (3)
- Fusion and Fission (3)
- Fusion Energy (1)
- Isotopes (5)
- Materials (35)
- National Security (8)
- Neutron Science (25)
- Quantum information Science (8)
- Supercomputing (98)
- Transportation Systems (2)
News Topics
- (-) Biomedical (4)
- (-) Quantum Science (3)
- (-) Summit (1)
- (-) Transportation (5)
- 3-D Printing/Advanced Manufacturing (8)
- Advanced Reactors (10)
- Bioenergy (2)
- Biology (1)
- Chemical Sciences (4)
- Climate Change (1)
- Composites (1)
- Computer Science (9)
- Coronavirus (4)
- Decarbonization (2)
- Energy Storage (4)
- Environment (1)
- Fusion (8)
- Isotopes (6)
- Materials (10)
- Materials Science (18)
- Microscopy (4)
- Molten Salt (4)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (9)
- Nuclear Energy (33)
- Physics (2)
- Polymers (6)
- Quantum Computing (1)
- Security (1)
- Simulation (1)
- Space Exploration (6)
- Sustainable Energy (6)
- Transformational Challenge Reactor (3)
Media Contacts
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.